Business Context and Reporting Period
This Form 8-K is a current report filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on May 25, 2017. The filing serves as a Regulation FD disclosure to distribute investor presentation materials used at the 18th Annual B. Riley Institutional Investor Conference held in Santa Monica, California.
Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. The document solely references the existence of an attached investor presentation (Exhibit 99.1) containing these details but does not reproduce the numerical data within the 8-K text itself.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The report is procedural, intended to make the presentation materials publicly available to satisfy disclosure obligations.
Guidance, Outlook, and Risks
- Management Commentary: The company explicitly disclaims any obligation to update the presentation materials or reflect events occurring after the date of this report.
- Legal Status: The information in Item 7.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Outlook: No specific forward-looking guidance is provided in the text of the 8-K; investors are directed to the attached presentation for such information.
Key Facts for Investor Verification
- Verify the actual financial figures and strategic outlook in Exhibit 99.1 (Investor Presentation dated May 2017), as they are not listed in this summary text.
- Confirm the company name is Second Sight Medical Products, Inc., as the input metadata incorrectly referenced Vivani Medical, Inc.
- Note that the presentation materials are "as of" May 25, 2017, and the company has no obligation to update them.
- Check the company's Investor Relations website (http://investors.secondsight.com) for the full presentation deck.